Last reviewed · How we verify
NCT00885456: PREVENT
Program of Rehabilitative Exercise and Education to Avert Vascular Events After Non-disabling Stroke or Transient Ischemic Attack: A Multi-site RCT
Phase 2 trial testing PREVENT program in Transient Ischemic Attack in 187 participants. Completed in 30 June 2017.
30 June 2017
Quick facts
| Lead sponsor | Marilyn MacKay-Lyons |
|---|---|
| Phase | Phase 2 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | health services research |
| Enrollment | 187 |
| Start date | 30 October 2011 |
| Primary completion | 30 June 2017 |
| Estimated completion | 30 June 2017 |
| Sites | 2 locations across Canada |
Drugs / interventions tested
- PREVENT program
- Usual Care
Conditions studied
- Transient Ischemic Attack — all drugs for Transient Ischemic Attack →
- Non-disabling Stroke — all drugs for Non-disabling Stroke →
Sponsor
Marilyn MacKay-Lyons
Who can join
17 and older, any sex, with Transient Ischemic Attack or Non-disabling Stroke. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The objective of the Program of Rehabilitative Exercise and Education to avert Vascular Events after Non-disabling stroke and Transient ischemic attack (PREVENT) Trial is to determine whether the timely delivery of secondary stroke prevention strategies will reduce modifiable vascular risk factors in two groups of people who have survived NDS or TIA. One group will receive a comprehensive education and exercise program (PREVENT); the other group will receive usual care (USUAL CARE). We will measure modifiable vascular risk factors in both groups. We will also compare the effects of PREVENT vs USUAL CARE on exercise capacity, walking endurance, and daily physical activity. In addition, we will compare thinking ability, depression, achievement of personal goals for healthy behavior, and health-related goal attainment and health-related quality of life. Finally, we will compare outcomes in urban and rural settings as well as costs of the PREVENT program and USUAL CARE in order to assess sustainability of the PREVENT program.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Program of rehabilitative exercise and education to avert vascular events after non-disabling stroke or transient ischemic attack (PREVENT Trial): a multi-centred, randomised controlled trial.
MacKay-Lyons M, Gubitz G, Giacomantonio N, Wightman H, et al · · 2010 · cited 29× · PMID 21143864 · DOI 10.1186/1471-2377-10-122 -
Program of Rehabilitative Exercise and Education to Avert Vascular Events After Non-Disabling Stroke or Transient Ischemic Attack (PREVENT Trial): A Randomized Controlled Trial.
MacKay-Lyons M, Gubitz G, Phillips S, Giacomantonio N, et al · · 2022 · cited 13× · PMID 34788569 · DOI 10.1177/15459683211060345
Verify or expand the search:
- PubMed search for NCT00885456
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Transient Ischemic Attack
Currently open trials in the same condition.
- NCT07242768 — Follow-up Extension Study of Regular Physical Exercise in Patients With Symptomatic Intracranial Arterial Stenosis · recruiting
- NCT06615726 — Regular Physical Exercise in Patients With Symptomatic Intracranial Arterial Stenosis · Phase 3 · active not recruiting
- NCT06515392 — TIA Scores' Mortality Predictions and Recurrent TIA and Stroke Prediction · recruiting
- NCT06653348 — Ticagrelor Based De-Escalation of Dual Antiplatelet Therapy in Ischemic Stroke · Phase 2, PHASE3 · recruiting
- NCT06091319 — Florbetaben for Imaging of Vascular Amyloid · recruiting
Other Marilyn MacKay-Lyons trials
Trials by the same sponsor.
- NCT01674790 — Combined Effects of Aerobic Exercise and Cognitive Training on Cognition After Stroke · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT00885456 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Marilyn MacKay-Lyons
- Last refreshed: 23 March 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT00885456.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing